Rutgers, The State University Of New Jersey

This early-stage study tested a two-part treatment for advanced skin cancer that had spread or returned. It combined a modified virus injected into the tumor to trigger the immune system with an antibody drug given by IV to block cancer growth. The main goals were to check the sa…

This early-stage study tested the safety of combining two immunotherapy drugs (atezolizumab and varlilumab) with targeted radiation in patients with advanced non-small cell lung cancer that had spread and stopped responding to standard treatments. The goal was to see if this thre…